Based on the recognized clinical significance of these molecular pathological subforms for glioma, glioma patients with elevated CD93 expression in tumor tissue may possess a high probability of neoplasm invasion, local recurrence, and treatment insensitivity. The gene discussed is CD93; the disease is glioma.